DIABETES AND SIGNAL TRANSDUCTION ABNORMALITIES
DIABETES AND SIGNAL TRANSDUCTION ABNORMALITIES
批准号:
2148825
负责人:
JOHN R. WILLIAMSON
金额:
$13.88万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-01 至 1999-08-31
关键词:
DNA replication G protein autocrine biological signal transduction calcium flux collagen diabetic nephropathy digital imaging eicosanoid metabolism enzyme activity glycosylation hormone regulation /control mechanism hyperglycemia immunofluorescence technique kidney cell laboratory rat microinjections mixed tissue /cell culture paracrine phospholipase A2 phospholipase C protein tyrosine kinase receptor coupling renal glomerulus single cell analysis
中文摘要
该提议背后的总体假设是糖尿病并发症
英文摘要
The overall hypothesis behind this proposal is that diabetic complications
in renal cells are due to specific malfunctions in signal transduction
mechanisms induced by hyperglycemia and abnormal glucose metabolism.
Prolonged hyperglycemia has two major consequences in affected tissues.
One is that there is an elevated level of diacylglycerol by de novo
synthesis from glucose, while the second is an accumulation of advanced
glycation end products (AGEs). These changes cause abnormal activation of
protein kinase C and an expansion of the extracellular matrix. The
effects of high glucose and AGE products on signaling pathways activated
in response to mitogenic and non-mitogenic agonists will be correlated
with functional changes in glomerular endothelial and mesangial cells in
solo or co-culture conditions. Powerful new techniques involving
microinjection of reagents and digital Ca2+ image analysis will be applied
to study the changes in cell signaling at the single cell level. Effects
of two classes of hormones, those that interact with receptors coupled to
G-proteins and those that contain or recruit tyrosine kinases, will be
investigated by using intracellular free Ca2+, PLA2 activity, DNA
synthesis and secretion of type IV collagen as functional parameters.
Steps in receptor-activated signal transduction pathways will be probed by
microinjection or use of fluorescent indicators, caged compounds,
antibodies and specific inhibitors. The following specific aims will be
addressed, l) the specificity of receptor-G-protein coupling will be
determined in glomerular endothelial and mesangial cells, 2) the mechanism
and regulation of hormone-induced Ca2+ oscillations will be investigated
in endothelial and mesangial cells, 3) the effects of high glucose and AGE
products will be measured on agonist-induced Ca2+ mobilization, DNA
synthesis, phospholipase A2 activity and secretion of type IV collagen,
and 4) effects of high glucose and AGE products on cell-cell signaling
mechanisms will be assessed in co-cultures of endothelial and mesangial
cells An important goal of the present work will be to define the
interplay of autocrine and paracrine factors between endothelial and
mesangial cells under conditions simulating the diabetic state. This
information will be critical for the development of future pharmacological
approaches for the prevention and treatment of diabetic nephropathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DIABETES AND SIGNAL TRANSDUCTION ABNORMALITIES
-
批准号:2148826
-
项目类别:
-
资助金额:$14.04万
-
财政年份:1995
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES AND SIGNAL TRANSDUCTION ABNORMALITIES
-
批准号:2770467
-
项目类别:
-
资助金额:$15.19万
-
财政年份:1995
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES AND SIGNAL TRANSDUCTION ABNORMALITIES
-
批准号:2518390
-
项目类别:
-
资助金额:$14.6万
-
财政年份:1995
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES AND SIGNAL TRANSDUCTION ABNORMALITIES
-
批准号:6197652
-
项目类别:
-
资助金额:$9.51万
-
财政年份:1995
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
GROWTH FACTOR CA++ SIGNALING IN ALCOHOLIC LIVER DISEASE
-
批准号:2291730
-
项目类别:
-
资助金额:$2.33万
-
财政年份:1993
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
GROWTH FACTOR CA++ SIGNALING IN ALCOHOLIC LIVER DISEASE
-
批准号:2291729
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1993
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
GROWTH FACTOR CA++ SIGNALING IN ALCOHOLIC LIVER DISEASE
-
批准号:3432685
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1993
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
STUDIES OF CARDIAC METABOLISM BY 13C AND 31P NMR
-
批准号:3340788
-
项目类别:
-
资助金额:$10.53万
-
财政年份:1983
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:2134832
-
项目类别:
-
资助金额:$15.18万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:2733881
-
项目类别:
-
资助金额:$17.25万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:3535209
-
项目类别:
-
资助金额:$13.98万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:2443821
-
项目类别:
-
资助金额:$15.43万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:2134833
-
项目类别:
-
资助金额:$14.6万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:2134835
-
项目类别:
-
资助金额:$14.81万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE, AND METABOLIC DISEASES
-
批准号:3535207
-
项目类别:
-
资助金额:$13.43万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:3535204
-
项目类别:
-
资助金额:$17.34万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:3535208
-
项目类别:
-
资助金额:$17.36万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
DIABETES, ENDOCRINE AND METABOLIC DISEASES
-
批准号:2134834
-
项目类别:
-
资助金额:$19.24万
-
财政年份:1978
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
CONTROL OF METABOLISM IN NORMAL AND DISEASE STATES
-
批准号:3225345
-
项目类别:
-
资助金额:$30.15万
-
财政年份:1976
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
CONTROL OF METABOLISM IN NORMAL AND DISEASE STATES
-
批准号:3225343
-
项目类别:
-
资助金额:$28.17万
-
财政年份:1976
-
负责人:JOHN R. WILLIAMSON
-
依托单位:
海外基金